Be an Early Applicant
The Role
The Senior Director of Investor Relations will lead communications with investors, shape corporate narratives, ensure compliance, and manage the company's public image while engaging with the investment community.
Summary Generated by Built In
Janux Therapeutics is seeking a seasoned and strategic Senior Director of Investor Relations to lead the company’s external engagement across the investment community, media, and broader public audiences. This role is instrumental in shaping Janux’s corporate narrative and ensuring transparent, consistent, and impactful communication of the company’s scientific progress, financial performance, and strategic priorities. The incumbent will report directly to the Chief Corporate and Business Development Officer, and collaborate closely with the CEO, CBO, Legal, and other senior stakeholders. This role demands a seasoned communicator with deep capital markets expertise, a sophisticated understanding of the biotech landscape, and the ability to translate complex scientific and business developments into compelling narratives that resonate with diverse external audiences.
ESSENTIAL FUNCTIONS AND RESPONSIBILITIES
- Develop and implement a comprehensive investor relations and corporate communications strategy aligned with Janux’s mission, pipeline milestones, and business objectives.
- Lead the development and management of external communications strategy, ensuring consistent messaging and brand representation across media, investor, and public channels.
- Build and refine Janux’s brand identity and messaging frameworks to resonate with investors, partners, and the broader biotech ecosystem, strengthening the company’s reputation and market positioning.
- Lead investor engagement initiatives including conferences, non-deal roadshows, R&D/Analyst Days, and KOL webinars.
- Drive investor targeting efforts, cultivating relationships with institutional investors, analysts, and banking partners aligned with Janux’s long-term vision.
- Manage the external communications calendar to ensure strategic alignment across investors, media, and public-facing channels.
- Serve as a key spokesperson to the investment community and media, representing Janux with clarity and credibility.
- Oversee the development of investor-facing and public communications, including earnings releases, investor presentations, press releases, website content, and executive briefing materials.
- Support the preparation and delivery of quarterly earnings calls, investor conferences, and other high-profile engagements.
- Ensure consistency and compliance across all external messaging, including SEC filings (10-K, 10-Q, 8-K, S-3), ESG disclosures, and material event communications.
- Monitor investor sentiment, stock performance, analyst coverage, and capital markets trends; synthesize insights to inform internal strategy and messaging.
- Track sell-side models and compare against internal forecasts to anticipate market expectations and proactively shape communications.
- Take ownership of understanding Janux’s competitive landscape and peer group within the biotech sector, and proactively assess and communicate Janux’s position and value proposition to internal stakeholders and leadership.
- Ensure compliance with SEC regulations, Reg FD, and Janux’s disclosure policies.
- Partner with Legal and Finance to ensure transparency, accuracy, and strategic alignment in all public disclosures.
- Support communications around clinical trial results, corporate transactions, and financing activities.
- Other duties as deemed necessary.
EDUCATION, EXPERIENCE, KNOWLEDGE, SKILLS AND ABILITIES
- Bachelor’s degree in Finance, Biology, Communications, or related field; advanced degree (MBA, PhD, or MS) preferred.
- Minimum of 10 years of experience in investor relations and/or corporate communications, ideally within a publicly traded biotech, pharmaceutical, or life sciences company.
- Exceptional communication skills, with the ability to translate complex scientific and business developments into clear, compelling narratives.
- Strong understanding of capital markets, investor behavior, and biotech valuation drivers.
- Familiarity with SEC regulations, disclosure obligations, and IR best practices.
- Established relationships with key investors, analysts, and media in the healthcare/life sciences space.
- Experience with IR and communications platforms and tools.
- Collaborative, proactive, and comfortable working in a fast-paced, science-driven environment.
- Strong ability to influence and partner with cross-functional teams and senior stakeholders.
- High level of integrity and commitment to ethical standards.
Job Type: Full-time
Benefits:
· 401K
· Medical insurance
· Dental insurance
· Vision insurance
· Supplemental disability insurance plans
· Flexible schedule
· Life insurance
· Flexible vacation
· Sick time
· Incentive stock option plan
· Relocation assistance
Schedule:
· Monday to Friday
Work authorization:
· United States (Required)
Additional Compensation:
· Annual targeted bonus %
Work Location:
· On site (San Diego, CA)
EQUAL OPPORTUNITY EMPLOYER:
Janux Therapeutics, Inc. is an equal opportunity employer that is committed to providing a work environment free of harassment and discrimination based upon a protected category, as well as an environment free from retaliation for protected activity.
Notice to Recruiters and Third-Party Agencies
The Talent Acquisition team manages the recruitment and employment process for Janux. To protect the interests of all parties involved, Janux will only accept resumes from a recruiter once a fully-executed search agreement is in place. Agencies are hereby specifically directed not to contact Janux employees directly in an attempt to present candidates. Janux will consider any candidate for whom an Agency and/or Recruiter has submitted an unsolicited resume to have been referred, free of any charges or fees.
Top Skills
Communications Tools
Ir Platforms
Sec Regulations
Am I A Good Fit?
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.
Success! Refresh the page to see how your skills align with this role.
The Company
What We Do
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.
